![](/img/cover-not-exists.png)
Is there or is there not a place for anti-interferon antibodies in the decision making of multiple sclerosis treatment optimisation?
N. Grigoriadis, G. Deretzi, N. Artemis, N. Tascos, I. MilonasVolume:
27
Language:
english
Pages:
1
DOI:
10.1007/s10072-006-0693-9
Date:
September, 2006
File:
PDF, 38 KB
english, 2006